Financials

People

Activity

NeuroVentures

Company

Investment-firm

Financing round

General

About Company
NeuroVentures is a venture capital firm that invests in companies that develop new treatments for central nervous system disorders.

Industry

Sector :

Subsector :

founded date

01.01.2000

Number of employees

IPO status

Private

Description

Founded in 2000 and based in Charlottesville, Virginia, NeuroVentures Capital invests in companies involved in the discovery, development, and marketing of new drugs, medical devices, and other therapeutics and technologies for treating central nervous system disorders.
Similar Companies
794
MRL Ventures Fund

MRL Ventures Fund

Merck's MRL Ventures is investing in breakthrough science to develop new medicines.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Financial Services, Venture Capital, Biotechnology

Location

Cambridge, MA, USA

total rounds

1

total raised

$18.74M

count Of Investments

32

count Of Exists

2
Chiesi Ventures

Chiesi Ventures

Chiesi Ventures is a venture capital firm that invests in early stage opportunities operating in the area of rare and orphan disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Venture Capital

Location

Boston, MA, USA

count Of Investments

13

count Of Exists

2
Amgen Ventures

Amgen Ventures

Amgen Ventures is a biotech-focused venture capital firm.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

San Francisco, CA, USA

count Of Investments

73

count Of Exists

10
CARB-X

CARB-X

CARB-X is a global non-profit partnership accelerating antibacterial R&D.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Boston, MA, USA

count Of Investments

114

count Of Exists

8

Financials

Investments
10
Date 
name 
Lead 
type 
Raised 
30.09.2010
No
$14M
01.03.2008
No
$30M
20.08.2007
No
$32M
NeurAxon

NeurAxon

NeurAxon, Inc. is a biopharmaceutical company that develops pain therapeutics targeting neuronal nitric oxide synthase.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Toronto, ON, Canada

total rounds

5

total raised

$57.41M
BrainCells

BrainCells

BrainCells is developing biopharmaceutical products for the treatment of central nervous system (CNS) diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Biopharma, Health Care

Location

San Diego, CA, USA

total rounds

5

total raised

$73.68M
NeurAxon

NeurAxon

NeurAxon, Inc. is a biopharmaceutical company that develops pain therapeutics targeting neuronal nitric oxide synthase.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Toronto, ON, Canada

total rounds

5

total raised

$57.41M
Co-Investors
Exits
1
BrainCells

BrainCells

BrainCells is developing biopharmaceutical products for the treatment of central nervous system (CNS) diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Biopharma, Health Care

Location

San Diego, CA, USA

total rounds

5

total raised

$73.68M

People

Employee Profiles
1
Steve LaPorte

Steve LaPorte

Vice President

Activity

Recent News
0